Back to top
more

Doximity (DOCS)

(Delayed Data from NYSE)

$28.96 USD

28.96
3,575,633

+0.93 (3.32%)

Updated May 20, 2024 04:00 PM ET

After-Market: $29.21 +0.25 (0.86%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (140 out of 249)

Industry: Medical Services

Better trading starts here.

Zacks News

Here's What Key Metrics Tell Us About Doximity (DOCS) Q1 Earnings

While the top- and bottom-line numbers for Doximity (DOCS) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Doximity (DOCS) Surpasses Q1 Earnings and Revenue Estimates

Doximity (DOCS) delivered earnings and revenue surprises of 26.67% and 1.40%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

DocGo Inc. (DCGO) Reports Q2 Loss, Tops Revenue Estimates

DocGo Inc. (DCGO) delivered earnings and revenue surprises of -166.67% and 4.89%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Avantor, Inc. (AVTR) Misses Q2 Earnings and Revenue Estimates

Avantor, Inc. (AVTR) delivered earnings and revenue surprises of -3.45% and 3.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Teladoc (TDOC) Reports Q2 Loss, Tops Revenue Estimates

Teladoc (TDOC) delivered earnings and revenue surprises of 9.09% and 0.52%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

ELV or DOCS: Which Is the Better Value Stock Right Now?

ELV vs. DOCS: Which Stock Is the Better Value Option?

Here's Why You Should Hold Centene (CNC) Stock for Now

Strong membership growth, contract wins, accretive acquisitions and the streamlining of businesses poise Centene (CNC) well for growth.

BLCO or DOCS: Which Is the Better Value Stock Right Now?

BLCO vs. DOCS: Which Stock Is the Better Value Option?

Doximity (DOCS) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Doximity (DOCS) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Doximity (DOCS) Q4 Earnings and Revenues Top Estimates

Doximity (DOCS) delivered earnings and revenue surprises of 17.65% and 0.78%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Nutex Health Inc. (NUTX) Reports Q1 Loss, Tops Revenue Estimates

Nutex Health Inc. (NUTX) delivered earnings and revenue surprises of 50% and 1.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Charles River Laboratories (CRL) Q1 Earnings and Revenues Beat Estimates

Charles River (CRL) delivered earnings and revenue surprises of 7.34% and 4.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Agilon Health (AGL) Surpasses Q1 Earnings and Revenue Estimates

Agilon (AGL) delivered earnings and revenue surprises of 33.33% and 5.25%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ELV or DOCS: Which Is the Better Value Stock Right Now?

ELV vs. DOCS: Which Stock Is the Better Value Option?

ELV or DOCS: Which Is the Better Value Stock Right Now?

ELV vs. DOCS: Which Stock Is the Better Value Option?

Doximity (DOCS) Surpasses Q3 Earnings and Revenue Estimates

Doximity (DOCS) delivered earnings and revenue surprises of 29.41% and 3.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AMN or DOCS: Which Is the Better Value Stock Right Now?

AMN vs. DOCS: Which Stock Is the Better Value Option?

AMN vs. DOCS: Which Stock Is the Better Value Option?

AMN vs. DOCS: Which Stock Is the Better Value Option?

AMN or DOCS: Which Is the Better Value Stock Right Now?

AMN vs. DOCS: Which Stock Is the Better Value Option?

AMN or DOCS: Which Is the Better Value Stock Right Now?

AMN vs. DOCS: Which Stock Is the Better Value Option?

AMN vs. DOCS: Which Stock Is the Better Value Option?

AMN vs. DOCS: Which Stock Is the Better Value Option?

Doximity (DOCS) Beats Q2 Earnings and Revenue Estimates

Doximity (DOCS) delivered earnings and revenue surprises of 6.25% and 2.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Bright Health Group (BHG) Reports Q3 Loss, Misses Revenue Estimates

Bright Health (BHG) delivered earnings and revenue surprises of 12.50% and 8.52%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) Reports Q3 Loss, Lags Revenue Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of -150% and 0.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Progyny (PGNY) Q3 Earnings and Revenues Top Estimates

Progyny (PGNY) delivered earnings and revenue surprises of 160% and 5.64%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?